Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepancies

Published:2024-09 Issue: Volume: Page:
ISSN:0749-6753
Container-title:The International Journal of Health Planning and Management
language:en
Short-container-title:Health Planning & Management

Author:

Ozaki Akihiko¹²^ORCID,Saito Hiroaki²³^ORCID,Endo Michioki²,Takebayashi Yoshitake⁴,Murakami Michio⁵

Affiliation:

1. Breast and Thyroid Center Jyoban Hospital of Tokiwa Foundation Iwaki Fukushima Japan

2. Medical Governance Research Institute Tokyo Japan

3. Department of Internal Medicine Soma Central Hospital Soma Fukushima Japan

4. Department of Health Risk Communication Fukushima Medical University School of Medicine Fukushima Japan

5. Center for Infectious Disease Education and Research (CiDER) Osaka University Suita Osaka Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hpm.3849

Reference8 articles.

1. Letter to Japanese physicians' perceptions of conflicts of interest with pharmaceutical companies: Estimating two different questioning approaches

2. Japan Pharmaceutical Manufactures Associations.Code of Practice;2019. Accessed 12 August 2024.https://www.jpma.or.jp/basis/code/lofurc0000001dqt‐att/code2.pdf

3. Real World Data Use in Pharmaceutical Companies in Japan： Current Status and Issues from Survey of Japan Pharmaceutical Manufacturers Association

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP